Modular Medical Announces Licensing and Partnership Agreement With Nudge BG
-Modular Medical will collaborate with Nudge BG to bring to market an adaptive full closed loop Automated Insulin Delivery system that does not require mealtime announcements-Effort will be led be Nudge BG founder and noted AID expert, Lane Desborough SAN DIEGO, CA /...
Jewett-Cameron Announces the Launch of the Adjust-A-Gate® Unlimited Low Profile Complete Gate Kit
A Flexible, Complete Solution for Professionals and DIY EnthusiastsNORTH PLAINS, Ore., Dec. 19, 2024 -- Jewett-Cameron Trading Company Ltd. (Nasdaq: JCTC), a company dedicated to designing innovative products that enhance outdoor living, is proud to announce its...
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference
WINTER SPRINGS, Fla., Dec. 19, 2024 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging ("MRI") compatible medical devices and the only provider of a non-magnetic intravenous ("IV") infusion pump system...
Cadrenal Therapeutics Gears Up for the 43rd Annual J.P. Morgan Healthcare Conference Week with Event Participation and Investor/Partner Meetings
Lays out Phase 3 Clinical and Regulatory Path for Tecarfarin and Three-Year Strategic Plan PONTE VEDRA, Fla. - Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), announced today its engagement in three key events leading up to and during the 43rd Annual J.P. Morgan...
Reviva Announces Pricing of $18.0 Million Public Offering of Common Stock and Warrants
CUPERTINO, Calif., Dec. 16, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Reviva Announces Proposed Public Offering
CUPERTINO, Calif., Dec. 16, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia
- Once daily brilaroxazine demonstrated favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year - - Generally well-tolerated with low rates of adverse events and discontinuation - - Full data set from open-label extension (OLE) of RECOVER...
Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia
- Once daily brilaroxazine demonstrated favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year - - Generally well-tolerated with low rates of adverse events and discontinuation - - Full data set from open-label extension (OLE) of RECOVER...
PolyPid Announces Research and Development Collaboration with ImmunoGenesis Leveraging PLEX Technology to Enhance Cancer Immunotherapy
PETACH TIKVA, Israel, Dec. 11, 2024 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced a new research and development collaboration with ImmunoGenesis, Inc....
NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation
RED has been designed to duplicate test performance of traditional balloon expulsion test (BET) and manual sensation testing devices without needing electronics or software. NeurAxis Inc. will begin the process of commercially marketing RED and expects initial...
IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025
WINTER SPRINGS, Fla., Dec. 10, 2024 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), today announced it has been ranked 24th on Forbes' list of America's Most Successful Small-Cap Companies 2025. Iradimed is a leader in the development of innovative magnetic...
Greenfire Resources Announces New Director Appointment
The Company Also Announces Date of Annual and Special Meeting of ShareholdersCalgary, Alberta--(December 9, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the production and development...
Greenfire Resources Announces Updated Reserves, 72% Increase in 2P Reserves with a $2.7 Billion NPV10 AT and an Evaluation that Incorporates the Company’s Future Growth Plans at the Hangingstone Facilities
Calgary, Alberta--(December 5, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the production and development of thermal energy resources from the Athabasca region of Alberta, Canada, is...
LiqTech Secures Landmark First Commercial Order for LiqTech PureFlow™ Mobile Units to the Oil & Gas Industry in North America
BALLERUP, Denmark, Dec. 5, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT), a leading innovator in specialized filtration technologies, is proud to announce a significant commercial order for LiqTech's PureFlow™ mobile units from Razorback Direct, based in...
Dror Ortho-Design Posts Updated CEO Investor Presentation
JERUSALEM, Dec. 04, 2024 -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), an AI-based orthodontic platform company that has developed a proprietary solution to correct people's smiles by straightening teeth using pulsating air delivered by a...
Modular Medical Announces Conference Call to Provide Business Update
SAN DIEGO, CA / December 3, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly...
ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) proudly announces its inclusion on the Inc. 2024 Best in Business list in the Health Products category. Inc.'s annual Best in Business Awards celebrate the exceptional achievements and contributions of companies that have...
PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
PETACH TIKVA, Israel, Nov. 29, 2024 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it has received a written notification (the "Notification Letter") from the...
Zoomd Technologies Reports Third Quarter 2024 Financial Results
Conference call will be held on November 29, 2024 at 11 AM ET TORONTO, Nov. 29, 2024 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech)...
S&W Files First Quarter 2025 10-Q
LONGMONT, Colo., Nov. 26, 2024 -- S&W Seed Company (Nasdaq: SANW) today announced it has filed its 10-Q for the three months ended September 30, 2024. S&W previously issued preliminary first quarter fiscal 2025 financial results on November 19, 2024. The...
S&W Finalizes Voluntary Plan of Administration Process for Australian Subsidiary
LONGMONT, Colo., Nov. 25, 2024 -- S&W Seed Company (Nasdaq: SANW) today announced it has finalized the voluntary plan of administration ("VA") process for its subsidiary, S&W Seed Company Australia Pty Ltd ("S&W Australia"). "As a result of the VA process...
InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024
Investor Presentation to be held at 10:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
Modular Medical Announces Pricing of $8.2 Million Public Offering
SAN DIEGO, CA / November 21, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly...
Modular Medical Announces Proposed Public Offering
SAN DIEGO, CA / November 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable...
Zoomd to Report Third Quarter 2024 Financial Results
VANCOUVER, BC, Nov. 21, 2024 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech) user-acquisition and engagement platform, announced today that it...